Quarterly report pursuant to Section 13 or 15(d)

EQUITY AND EARNINGS PER SHARE

v3.20.2
EQUITY AND EARNINGS PER SHARE
 9 Months Ended
Sep. 30, 2020
Stockholders' Equity Note [Abstract]  
EQUITY AND EARNINGS PER SHARE EQUITY AND EARNINGS PER SHARE
 
A. Stock Options

The following is a summary of the changes in the Company’s outstanding options for the nine months ended September 30, 2020:
Number of Options Weighted Average Strike Price Weighted Average Life Remaining (in years)
Balance at December 31, 2019 6,898,346  $ 3.26 
Expired (1,117,118) 5.44 
Forfeited (770,652) 4.74 
Balance at September 30, 2020 5,010,576  $ 2.55  2.42
Exercisable at September 30, 2020 3,702,422  $ 2.56  2.44

As of September 30, 2020, the Company’s outstanding options were summarized as follows:
Number of Options
Held by the former Manager 3,627,245 
Issued to the former Manager and subsequently transferred to certain of the Manager’s employees (A) 1,382,998 
Issued to the independent directors 333 
Total 5,010,576 
Weighted average strike price $ 2.55 
(A)The Company and the former Manager agreed that options held by certain employees formerly employed by the Manager would not terminate or be forfeited as a result of the Termination and Cooperation Agreement, and the vesting of such options relate to the relevant holder’s employment with the Company and its affiliates following January 1, 2018. In both February 2017 and April 2018, the former Manager issued 1,152,495 options to certain employees formerly employed by the Manager as part of their compensation. The options fully vest and are exercisable one year prior to the option expiration date, beginning March 2020 through January 2024. In July 2019, a certain employee was terminated by the Company and 921,992 options reverted back to the former Manager. 

Stock-based compensation expense is recognized on a straight-line basis through the vesting date of the options. Stock-based compensation expense related to the employee options was $0.3 million and $0.5 million during the three and nine months ended September 30, 2020, respectively, and $(0.1) million and $2.3 million during the three and nine months ended September 30, 2019, respectively, and was recorded in general and administrative expense on the Consolidated Statements of Operations. The unrecognized stock-based compensation expense related to the unvested options was $1.4 million as of September 30, 2020 and will be expensed over a weighted average of 1.8 years.

B. Restricted Stock Units ("RSUs")

The following is a summary of the changes in the Company’s RSUs for the nine months ended September 30, 2020.
Number of RSUs Weighted Average Grant Date Fair Value (per unit)
Balance at December 31, 2019 520,618  $ 4.66 
Released (159,193) $ 4.69 
Forfeited (144,447) $ 4.62 
Balance at September 30, 2020 216,978  $ 4.67 
The Company grants RSUs to the non-employee directors as part of their annual compensation. The RSUs are subject to a one year vesting period. During the nine months ended September 30, 2020, the Company granted no RSUs to non-employee directors and 37,944 RSUs granted to non-employee directors vested. The Company also grants RSUs to employees as part of their annual compensation. The RSUs vest in equal annual installments on each of the first three anniversaries of the grant date. During the nine months ended September 30, 2020, the Company granted no RSUs to employees and 160,954 RSUs granted to employees vested. Stock-based compensation expense is recognized on a straight-line basis through the vesting date of the RSUs. Stock-based compensation expense related to RSUs was $0.2 million and $0.6 million during the three and nine months ended September 30, 2020, respectively, and $0.3 million and $0.5 million for the three and nine months ended September 30, 2019, respectively. Stock-based compensation expense was recorded in general and administrative expense on the Consolidated Statements of Operations. The unrecognized stock-based compensation expense related to the unvested RSUs was $0.6 million as of September 30, 2020 and will be expensed over a weighted average of 1.6 years.

C. Dividends

On November 11, 2019, the Company declared dividends of $0.609375, $0.503125 and $0.523438 per share on the 9.750% Series B, 8.050% Series C and 8.375% Series D preferred stock, respectively, for the period beginning November 1, 2019 and ending January 31, 2020. Dividends totaling $1.4 million were paid on January 31, 2020. No dividends were declared during the nine months ended September 30, 2020.

D. Earnings Per Share

The following table shows the Company's basic and diluted earnings per share (“EPS”):
Three Months Ended September 30, Nine Months Ended September 30,
2020 2019 2020 2019
Numerator for basic and diluted earnings per share:
Loss from continuing operations after preferred dividends and noncontrolling interests $ (10,807) $ (13,414) $ (70,485) $ (43,763)
Loss Applicable to Common Stockholders $ (10,807) $ (13,414) $ (70,485) $ (43,763)
Denominator:
Denominator for basic earnings per share - weighted average shares 67,212,532  67,040,692  67,131,827  67,032,519 
Effect of dilutive securities
Options —  —  —  — 
RSUs —  —  —  — 
Denominator for diluted earnings per share - adjusted weighted average shares 67,212,532  67,040,692  67,131,827  67,032,519 
Basic earnings per share:
Loss from continuing operations per share of common stock, after preferred dividends and noncontrolling interests $ (0.16) $ (0.20) $ (1.05) $ (0.65)
Loss Applicable to Common Stock, per share $ (0.16) $ (0.20) $ (1.05) $ (0.65)
Diluted earnings per share:
Loss from continuing operations per share of common stock, after preferred dividends and noncontrolling interests $ (0.16) $ (0.20) $ (1.05) $ (0.65)
Loss Applicable to Common Stock, per share $ (0.16) $ (0.20) $ (1.05) $ (0.65)
The Company’s dilutive securities are outstanding stock options and RSUs. During the three and nine months ended September 30, 2020, based on the treasury stock method, the Company had 450,498 and 632,722 potentially dilutive securities, respectively, which were excluded due to the Company's loss position. During the three and nine months ended September 30, 2019, based on the treasury stock method, the Company had 1,915,008 and 2,328,494 potentially dilutive securities, respectively.